US 8440679
Bicyclic compounds and their uses as dual c-SRC / JAK inhibitors
granted A61PA61P19/00A61P19/08
Quick answer
US patent 8440679 (Bicyclic compounds and their uses as dual c-SRC / JAK inhibitors) held by Aurigene Discovery Technologies Limited expires Mon May 09 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Aurigene Discovery Technologies Limited
- Grant date
- Tue May 14 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 09 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61P, A61P19/00, A61P19/08, A61P35/00, A61P35/02